In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Several CRISPR-Cas9 orthologues have been used for genome editing. Here, we present the smallest Cas9 orthologue characterized to date, derived from Campylobacter jejuni (CjCas9), for efficient genome editing in vivo . After determining protospacer-adjacent motif (PAM) sequences and optimizing single-guide RNA (sgRNA) length, we package the CjCas9 gene, its sgRNA sequence, and a marker gene in an all-in-one adeno-associated virus (AAV) vector and produce the resulting virus at a high titer. CjCas9 is highly specific, cleaving only a limited number of sites in the human or mouse genome. CjCas9, delivered via AAV, induces targeted mutations at high frequencies in mouse muscle cells or retinal pigment epithelium (RPE) cells. Furthermore, CjCas9 targeted to the Vegfa or Hif1a gene in RPE cells reduces the size of laser-induced choroidal neovascularization, suggesting that in vivo genome editing with CjCas9 is a new option for the treatment of age-related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Smaller genome editing proteins, such as the S. aureus Cas9, C. jejuni Cas9 and newly identified CRISPR-Cas enzymes, may circumvent this issue 23,61-65 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The downregulation was linked to a decrease in spot size on morphology of the laser-induced choroidal neovascularization (wet AMD model) but not on retinal function measured by electroretinogram (ERG) [221].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [221]
The cited source says what the claim attributes to it.
In the citing paper
“Fonfara et al. previously reported the optimal in vitro PAM site for CjCas9 to be 5′-NNNNACA”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
The cited source says what the claim attributes to it.
In the citing paper
“In February 2017, Kim et al. presented efficient in vivo genome editing using the smallest Cas9 orthologue (2.95 kb) that has been characterized as of February 2017: Campylobacter jejuni (CjCas9) [72].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
The cited source says what the claim attributes to it.
In the citing paper
“In February 2017, Kim et al. presented efficient in vivo genome editing using the smallest Cas9 orthologue (2.95 kb) that has been characterized as of February 2017: Campylobacter jejuni (CjCas9) [72].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Bae, S., Park, J., & Kim, J.-S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu048 · Cited by 2,339
Self-citationRNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Self-citationStructural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Cited by
Items 301–400 of 730
Escobar, M., Li, J., Patel, A., Liu, S., Xu, Q., & Hilton, I. B. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00156 · Cited by 28
Isonitrile-Tetrazine Click-and-Release Chemistry for Controlling RNA-Guided Nucleic Acid Cleavage
Ji, H., Xiong, W., Guo, S., Wang, S., Xing, X., Tian, T., & Zhou, X. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00255 · Cited by 25
Sastre, D., Zafar, F., Torres, C. A. M., Piper, D., Kirik, D., Sanders, L. H., Qi, L. S., & Schüle, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-45078-3 · Cited by 26
CRISPR Editing Technology in Biological and Biomedical Investigation
White, M. K., Kaminski, R., Young, W., Roehm, P. C., & Khalili, K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26099 · Cited by 27
Genome editing in the mammalian brain using the CRISPR–Cas system
Nishiyama, J. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.003 · Cited by 26
Kwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H., Eom, J.-H., et al. (2023) · Genome biology · doi:10.1186/s13059-022-02842-4 · Cited by 24
“The Streptococcus pyogenes Cas9 sequence [38] and the designed promiscuous sgRNA sequences that target Albumin and PCSK9 were cloned into the AAV plasmid back-bone used in a previous study [39] to create Cas9 (pAAV-Cas9) and sgRNA (pAAV-Albumin and pAAV-PCSK9) expression vectors.”
MethodSelf-citationLive-Animal Epigenome Editing: Convergence of Novel Techniques
Gomez, J. A., Beitnere, U., & Segal, D. J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.007 · Cited by 24
Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina
Li, F., Hung, S. S. C., Mohd Khalid, M. K. N., Wang, J.-H., Chrysostomou, V., Wong, V. H. Y., Singh, V., Wing, K., Tu, L., Bender, J. A., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.021 · Cited by 24
CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases
Rasoulinejad, S. A., & Maroufi, F. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00345-4 · Cited by 26
Asano, Y., Yamashita, K., Hasegawa, A., Ogasawara, T., Iriki, H., & Muramoto, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-89546-0 · Cited by 24
Compact SchCas9 Recognizes the Simple NNGR PAM
Wang, S., Mao, H., Hou, L., Hu, Z., Wang, Y., Qi, T., Tao, C., Yang, Y., Zhang, C., Li, M., et al. (2021) · Advanced Science · doi:10.1002/advs.202104789 · Cited by 27
CRISPR-Based Genome-Editing Tools for Huntington’s Disease Research and Therapy
Qin, Y., Li, S., Li, X., & Yang, S. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00880-3 · Cited by 26
Versatile High-Throughput Fluorescence Assay for Monitoring Cas9 Activity
Seamon, K. J., Light, Y. K., Saada, E. A., Schoeniger, J. S., & Harmon, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01155 · Cited by 25
In Silico Processing of the Complete CRISPR‐Cas Spacer Space for Identification of PAM Sequences
Mendoza, B. J., & Trinh, C. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700595 · Cited by 26
Torregrosa, T., Lehman, S., Hana, S., Marsh, G., Xu, S., Koszka, K., Mastrangelo, N., McCampbell, A., Henderson, C. E., & Lo, S. (2021) · Gene Therapy · doi:10.1038/s41434-021-00223-3 · Cited by 24
Development and Application of CRISPR-Cas Based Tools
Hu, Y., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.834646 · Cited by 26
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
Wu, Y., Xiao, Y., & Tang, W. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02678-w · Cited by 24
DNA targeting by Clostridium cellulolyticum CRISPR–Cas9 Type II-C system
Fedorova, I., Arseniev, A., Selkova, P., Pobegalov, G., Goryanin, I. I., Vasileva, A., Musharova, O. S., Abramova, M., Kazalov, M., Zyubko, T., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1225 · Cited by 23
CRISPR Toolbox for Genome Editing in Dictyostelium
Yamashita, K., Iriki, H., Kamimura, Y., & Muramoto, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721630 · Cited by 25
Structural and dynamic insights into the HNH nuclease of divergent Cas9 species
Belato, H. B., D’Ordine, A. M., Nierzwicki, Ł., Arantes, P. R., Jogl, G., Palermo, G., & Lisi, G. P. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107814 · Cited by 23
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG
Yu, S.-Y., Birkenshaw, A., Thomson, T., Carlaw, T., Zhang, L., & Ross, C. J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0109 · Cited by 25
Zhou, W., Yang, J., Zhang, Y., Hu, X., & Wang, W. (2022) · MedComm · doi:10.1002/mco2.155 · Cited by 31
Chen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 25
Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM
Qi, T., Wang, Y., Yang, Y., Gao, S., Liu, J., Huang, Q., Tian, Y., Tang, J., Zheng, W., & Wang, Y. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01481-5 · Cited by 23
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle, C. F., & MacLaren, R. E. (2017) · PubMed Central · Cited by 33
Stephenson, A. A., Nicolau, S., Vetter, T. A., Dufresne, G., Frair, E. C., Sarff, J., Wheeler, G. L., Kelly, B., White, P., & Flanigan, K. M. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.08.009 · Cited by 23
Advancing crop improvement through GWAS and beyond in mung bean
Ahmed, S. R., Asghar, M. J., Hameed, A., Ghaffar, M., & Shahid, M. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1436532 · Cited by 24
CRISPR-Cas technology for rapid detection of pathogens
Daneshgar, H., Safarkhani, M., Sojdeh, S., Bagherzadeh, M., & Rabiee, N. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118174 · Cited by 22
Applications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational Research
Lau, C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0026 · Cited by 24
Yue, J.-J., Hong, C., Wei, P., Tsai, Y., & Lin, C. (2020) · Rice · doi:10.1186/s12284-019-0354-2 · Cited by 25
Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife
Meaker, G. A., Hair, E. J., & Gorochowski, T. E. (2020) · Synthetic Biology · doi:10.1093/synbio/ysaa021 · Cited by 24
Characterization of Brevibacillus laterosporus Cas9 (BlatCas9) for Mammalian Genome Editing
Gao, N., Zhang, C., Hu, Z., Li, M., Wei, J., Wang, Y., & Liu, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.583164 · Cited by 22
Review, analysis, and optimization of the CRISPR Streptococcus pyogenes Cas9 system
Wang, G., & Li, J. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100080 · Cited by 22
CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip
Peyravian, N., Kebria, M. M., Kiani, J., Milan, P. B., & Mozafari, M. (2021) · Materials · doi:10.3390/ma14123164 · Cited by 22
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s
Hou, S., Lee, J. M., Myint, W., Matsuo, H., Yılmaz, N. K., & Schiffer, C. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100909 · Cited by 23
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 26
Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA
Selkova, P., Vasileva, A., Pobegalov, G., Musharova, O. S., Arseniev, A., Kazalov, M., Zyubko, T., Shcheglova, N., Artamonova, T., Khodorkovskii, M. A., et al. (2020) · RNA Biology · doi:10.1080/15476286.2020.1777378 · Cited by 21
Sophisticated CRISPR/Cas tools for fine-tuning plant performance
Capdeville, N., Merker, L., Schindele, P., & Puchta, H. (2020) · Journal of Plant Physiology · doi:10.1016/j.jplph.2020.153332 · Cited by 22
CRISPR Technology for Ocular Angiogenesis
Chung, S. H., Sin, T.-N., Ngo, T., & Yiu, G. C. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.594984 · Cited by 21
Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery
Kweon, J., Jang, A.-H., Kwon, E., Kim, U. G., Shin, H. R., See, J.-E., Jang, G., Lee, C., Koo, T., Kim, S., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00938-w · Cited by 21
Self-citationAdvances in CRISPR/Cas gene therapy for inborn errors of immunity
Liu, X., Li, G., Liu, Y., Zhou, F., Huang, X., & Li, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111777 · Cited by 28
Seo, S.-Y., Min, S., Lee, S., Seo, J. H., Park, J., Kim, H. K., Song, M., Baek, D., Cho, S., & Kim, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01875-2 · Cited by 22
Self-citationGenetic Databases and Gene Editing Tools for Enhancing Crop Resistance against Abiotic Stress
Joshi, A. B., Yang, S.-Y., Song, H.-G., Min, J., & Lee, J.-H. (2023) · Biology · doi:10.3390/biology12111400 · Cited by 25
Genome editing using CRISPR, CAST, and Fanzor systems
Song, B., & Bae, S. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100086 · Cited by 22
Yuen, C. T. L., Thean, D., Chan, B. K. C., Zhou, P., Kwok, C. C. S., Chu, H. Y., Cheung, M. S. H., Wang, B., Chan, Y. M., Mak, S. Y. L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1291 · Cited by 23
Rybnicky, G. A., Fackler, N., Karim, A. S., Köpke, M., & Jewett, M. C. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac142 · Cited by 26
Saeed, S., Khan, S. U., Khan, W. U., Abdel-Maksoud, M. A., Mubarak, A., Aufy, M., Kiani, F. A., Wahab, A., Shah, M. W., & Saleem, M. H. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101692 · Cited by 24
Park, J., Cui, G., Lee, H., Jeong, H., Kwak, J. J., Lee, J., & Byeon, S. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-29014-z · Cited by 20
Ghosh, S., Lahiri, D., Nag, M., Sarkar, T., Pati, S., Edinur, H. A., Kumar, M., Zain, M. R. A. M., & Ray, R. R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.964848 · Cited by 26
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering
Eghbalsaied, S., Lawler, C., Petersen, B., Hajiyev, R. A., Bischoff, S. R., & Frankenberg, S. (2024) · Gene Therapy · doi:10.1038/s41434-023-00434-w · Cited by 20
Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina
Yu, W., & Wu, Z. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9139-6_7 · Cited by 20
CRISPRpic: fast and precise analysis for CRISPR-induced mutations via p refixed i ndex c ounting
Lee, H., Chang, H. Y., Cho, S. W., & Ji, H. P. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa012 · Cited by 21
Begemann, M. B., Gray, B. N., January, E., Singer, A., Kesler, D. C., He, Y., Liu, H., Guo, H., Jordan, A., Brutnell, T. P., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/192799 · Cited by 20
Customizing CRISPR–Cas PAM specificity with protein language models
Nayfach, S., Bhatnagar, A., Novichkov, A., Kim, N., Hoffnagle, A. M., Hussain, R., Estevam, G. O., Hill, E., Ruffolo, J. A., Silverstein, R. A., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02995-0 · Cited by 25
Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing
Hernández-Juárez, J., Rodríguez‐Uribe, G., & Borooah, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.698521 · Cited by 22
Lee, J. H., Oh, H.-K., Choi, B. S., Lee, H. H., Lee, K. J., Kim, U. G., Lee, J., Lee, H.-R., Lee, G. S., Ahn, S. J., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.002 · Cited by 19
Self-citationAdvances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 20
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
Lau, C., Liang, Q., & Zhu, H. (2024) · Transgenic Research · doi:10.1007/s11248-024-00404-x · Cited by 20
Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
Degtev, D., Bravo, J. P. K., Emmanouilidi, A., Zdravković, A., Choong, O. K., Touza, J. L., Selfjord, N., Weisheit, I., Francescatto, M., Akçakaya, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53418-8 · Cited by 22
CRISPR genome engineering for retinal diseases
Kantor, A., McClements, M. E., Peddle, C. F., Fry, L. E., Salman, A., Cehajic‐Kapetanovic, J., Xue, K., & MacLaren, R. E. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.024 · Cited by 22
Advances in Accurate Microbial Genome-Editing CRISPR Technologies
Lee, H. J., & Lee, S. J. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2106.06056 · Cited by 21
CRISPR Systems Suitable for Single AAV Vector Delivery
Stevanovic, M., Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Current Gene Therapy · doi:10.2174/1566523221666211006120355 · Cited by 19
CRISPR-based functional genomics tools in vertebrate models
Varshney, G. K., & Burgess, S. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01514-0 · Cited by 25
Applications of CRISPR-Cas Technologies to Proteomics
Dolgalev, G. V., & Poverennaya, E. V. (2021) · Genes · doi:10.3390/genes12111790 · Cited by 18
Internally inlaid SaCas9 base editors enable window specific base editing
Jiang, L., Long, J., Yang, Y., Zhou, L., Su, J., Qin, F., Tang, W., Tao, R. X., Chen, Q., & Yao, S. (2022) · Theranostics · doi:10.7150/thno.70869 · Cited by 18
Technologies Enabling Single-Molecule Super-Resolution Imaging of mRNA
Tingey, M., Schnell, S. J., Yu, W., Saredy, J., Junod, S. L., Patel, D., Alkurdi, A., & Yang, W. (2022) · Cells · doi:10.3390/cells11193079 · Cited by 21
Wang, S., Tao, C., Mao, H., Hou, L., Wang, Y., Qi, T., Yang, Y., Ong, S., Hu, S., Chai, R., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001897 · Cited by 20
Optimization of CRISPR–Cas system for clinical cancer therapy
Meng, X. L., Wu, T., Lou, Q., Niu, K., Jiang, L., Xiao, Q., Xu, T., & Zhang, L. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10474 · Cited by 19
Updates and Applications of CRISPR/Cas Technology in Plants
Vidya, N., & Arun, M. (2023) · Journal of Plant Biology · doi:10.1007/s12374-023-09383-8 · Cited by 19
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
Padmaswari, M. H., Agrawal, S., Jia, M. S., Ivy, A., Maxenberger, D. A., Burcham, L. A., & Nelson, C. E. (2023) · Biophysics Reviews · doi:10.1063/5.0131452 · Cited by 19
Reprogramming an RNA-guided archaeal TnpB endonuclease for genome editing
Xu, Y. C., Liu, T., Wang, J., Xiong, B., Liu, L., & Peng, N. (2023) · Cell Discovery · doi:10.1038/s41421-023-00615-2 · Cited by 20
CRISPR/Cas9 as a Mutagenic Factor
Shumega, A. R., Pavlov, Y. I., Chirinskaite, A. V., Rubel, A. A., Inge-Vechtomov, S. G., & Stepchenkova, E. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020823 · Cited by 18
Robust miniature Cas-based transcriptional modulation by engineering Un1Cas12f1 and tethering Sso7d
Wang, X., Li, L., Guo, L., Feng, Y. J., Du, Z., Jiang, W., Wu, X., Zheng, J., Xiao, X., Zheng, H., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.02.013 · Cited by 18
CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come
Ren, C., Mohamed, M. S. M., Aini, N., Kuang, Y., & Liang, Z. (2024) · Horticulturae · doi:10.3390/horticulturae10090965 · Cited by 20
AAV-mediated gene therapies by miniature gene editing tools
Kong, X., Li, T., & Yang, H. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2608-5 · Cited by 20
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
Recent advances in CRISPR technologies for genome editing
Song, M., & Koo, T. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01336-4 · Cited by 18
Self-citationYoo, K. H., Hennighausen, L. G., & Shin, H. Y. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9417-z · Cited by 18
A Simple Cloning-free Method to Efficiently Induce Gene Expression Using CRISPR/Cas9
Fang, L., Hung, S. S. C., Yek, J., Wazan, L. E., Nguyen, T., Khan, S., Lim, S. Y., Hewitt, A. W., & Wong, R. C. B. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.11.008 · Cited by 22
CRISPR/Cas Toolbox: Unveiling the secret weapon for SNP detection
Chai, L., Cui, X., Liu, H., Zhang, Y., Pan, Y., Li, C., & Le, T. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118321 · Cited by 17
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo
Bestas, B., Wimberger, S., Degtev, D., Madsen, A., Rottner, A. K., Karlsson, F. H., Naumenko, S., Callahan, M., Touza, J. L., Francescatto, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41240-7 · Cited by 20
Wang, H., Zhou, J., Lei, J., Mo, G., Wu, Y., Liu, H., Pang, Z., Du, M., Zhou, Z., Paek, C., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002619 · Cited by 17
DNA targeting by compact Cas9d and its resurrected ancestor
Ocampo, R. F., Bravo, J. P. K., Dangerfield, T. L., Nocedal, I., Jirde, S. A., Alexander, L. M., Thomas, N. C., Das, A., Nielson, S., Johnson, K. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55573-4 · Cited by 20
Jyoti, A., Kaushik, S., Srivastava, V. K., Datta, M., Kumar, S., Yugandhar, P., Kothari, S. L., Rai, V., & Jain, A. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.03.010 · Cited by 21
马迅, Ma, X., 黄芯渝, 谭晞彦, 崔雍建, 钟礼瞬, 冯波, Wong, A. S.-Y., Tam, H.-Y., Tsui, S. Y.-K., et al. (2018) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2017.012 · Cited by 17
Rewriting CFTR to cure cystic fibrosis
Maule, G., Ensinck, M. M., Bulcaen, M., & Carlon, M. S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.018 · Cited by 19
CRISPR, animals, and FDA oversight: Building a path to success
Epstein, L. R., Lee, S. S., Miller, M. F., & Lombardi, H. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004831117 · Cited by 18
Kim, U., & Shin, H. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911297 · Cited by 17
Burnight, E. R., Bohrer, L. R., Giacalone, J. C., Klaahsen, D., Daggett, H. T., East, J. S., Madumba, R. A., Worthington, K. S., Mullins, R. F., Stone, E. M., et al. (2018) · The CRISPR Journal · doi:10.1089/crispr.2017.0015 · Cited by 17
Generation of genetically modified mice using SpCas9-NG engineered nuclease
Fujii, W., Ito, H., Kanke, T., Ikeda, A., Sugiura, K., & Naito, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-49394-5 · Cited by 16
Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
He, J., Biswas, R., Bugde, P., Li, J., Liu, D., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050894 · Cited by 18
Next-generation biological vector platforms for in vivo delivery of genome editing agents
Leclerc, D., Siroky, M. D., & Miller, S. M. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.103040 · Cited by 17
Banda, A., Impomeni, O., Singh, A., Baloch, A. R., Hu, W., & Jaijyan, D. K. (2024) · Vaccines · doi:10.3390/vaccines12060636 · Cited by 17
Chey, Y. C. J., Gierus, L., Lushington, C., Arudkumar, J., Geiger, A., Staker, L. G., Robertson, L. J., Pfitzner, C., Kennedy, J. G., Lee, R. H. B., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-11317-2 · Cited by 16
Genetic Approaches for the Treatment of Facioscapulohumeral Muscular Dystrophy
Lim, K. R. Q., & Yokota, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.642858 · Cited by 16
Genome editing with natural and engineered CjCas9 orthologs
Gao, S., Wang, Y., Qi, T., Wei, J., Hu, Z., Liu, J., Sun, S., Liu, H., & Wang, Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.029 · Cited by 18
Versatile Genome Engineering Techniques Advance Human Ocular Disease Researches in Zebrafish
Zheng, S., Han, R., Xiang, L., Zhuang, Y., & Jin, Z. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00075 · Cited by 16
Eukaryotic-driven directed evolution of Cas9 nucleases
(2024) · doi:10.1186/s13059-024-03215-9 · Cited by 15
Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
Mariot, V., & Dumonceaux, J. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.937879 · Cited by 17
Metadata
- Authors
- Kim, E., Koo, T., Park, S. W., Kim, D., Kim, K., Cho, H.-Y., Song, D. W., Lee, K. J., Jung, M. H., Kim, S., Kim, J. H., Kim, J. H., & Kim, J.-S.
- Affiliations
- Institute for Basic Science (KR)
- Seoul National University (KR)
- ToolGen (South Korea) (KR)
- Corresponding author
- Kim, Jeong Hun
- ORCID
- Venue
- Nature Communications
- Published
- 2017-02-21
- Volume
- 8
- Issue
- 1
- Pages
- 14500-14500
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5473640
- OpenAlex
- W2590764628
- Cited by
- 715
- References
- 38
- Citations by year
- 2026: 24 · 2025: 68 · 2024: 68 · 2023: 81 · 2022: 114 · 2021: 94 · 2020: 87 · 2019: 77 · 2018: 66 · 2017: 36
- FWCI
- 29.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Research Foundation (NRF-2015M3A9E6028949)
- Ministry of Science, ICT and Future Planning (NRF-2015M3A9E6028949, IBS-R021-D1, 2015M3A9E6028949)
- Korea Health Industry Development Institute (HI16C0426)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- in vivo gene editing, adeno-associated virus vectors, single guide RNA, protospacer adjacent motif, retinal pigment epithelium, choroidal neovascularization, age-related macular degeneration, VEGF-A, HIF1A, targeted mutagenesis
- MeSH terms
- Gene Editing, Dependovirus, Animals, Bacterial Proteins, Cells, Cultured, Endonucleases, Humans, Male, Mice, Inbred C57BL, Campylobacter jejuni, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Retinal Pigment Epithelium, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.